Insufficient scRNA-seq data for expression of OC90 at single-cell level.
Insufficient scRNA-seq data for expression of OC90 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 68% | 7.44 | 1805 / 2642 | 0% | 0 | 0 / 705 |
adipose | 24% | 1.26 | 289 / 1204 | 0% | 0 | 0 / 0 |
thymus | 21% | 0.67 | 137 / 653 | 0% | 0 | 0 / 605 |
skin | 19% | 0.94 | 344 / 1809 | 0% | 0 | 0 / 472 |
lung | 15% | 0.42 | 86 / 578 | 0% | 0 | 0 / 1155 |
prostate | 15% | 0.49 | 36 / 245 | 0% | 0 | 0 / 502 |
breast | 11% | 0.48 | 52 / 459 | 0% | 0 | 0 / 1118 |
kidney | 10% | 0.27 | 9 / 89 | 0% | 0.00 | 1 / 901 |
pancreas | 10% | 0.30 | 33 / 328 | 0% | 0 | 0 / 178 |
bladder | 10% | 0.24 | 2 / 21 | 0% | 0 | 0 / 504 |
intestine | 9% | 0.25 | 89 / 966 | 0% | 0 | 0 / 527 |
blood vessel | 9% | 0.24 | 115 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 8% | 0.20 | 114 / 1445 | 0% | 0 | 0 / 183 |
spleen | 7% | 0.26 | 18 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 0.17 | 18 / 258 | 0% | 0 | 0 / 230 |
heart | 5% | 0.10 | 39 / 861 | 0% | 0 | 0 / 0 |
ovary | 4% | 0.09 | 8 / 180 | 0% | 0 | 0 / 430 |
stomach | 4% | 0.09 | 14 / 359 | 0% | 0 | 0 / 286 |
uterus | 4% | 0.07 | 6 / 170 | 0% | 0 | 0 / 459 |
muscle | 3% | 0.06 | 22 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 0.05 | 20 / 929 | 0% | 0 | 0 / 0 |
liver | 1% | 0.03 | 3 / 226 | 0% | 0 | 0 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0045299 | Biological process | otolith mineralization |
GO_0008150 | Biological process | biological_process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005575 | Cellular component | cellular_component |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005509 | Molecular function | calcium ion binding |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005198 | Molecular function | structural molecule activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | OC90 |
Protein name | Otoconin-90 (Oc90) (Phospholipase A2 homolog) |
Synonyms | PLA2L |
Description | FUNCTION: Major protein of the otoconia, a calcium carbonate structure in the saccule and utricle of the ear. Together with OTOL1, acts as a scaffold for otoconia biomineralization: sequesters calcium and forms interconnecting fibrils between otoconia that are incorporated into the calcium crystal structure. Together with OTOL1, modulates calcite crystal morphology and growth kinetics. It is unlikely that this protein has phospholipase A2 activity. . |
Accessions | Q02509 ENST00000254627.4 [Q02509-1] |